Looking first at the protein level, we did not find a difference in terms of IL-22BP protein in the sera of 63 MS patients versus 13 healthy controls (HC); however, there was a trend (p = 0.14) towards an increased secretion of IL-22BP in MS patients as compared to HC (Fig. 1f). The gene discussed is IL22RA2; the disease is myeloid sarcoma.